512 related articles for article (PubMed ID: 19476377)
1. DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.
Pommier Y
Chem Rev; 2009 Jul; 109(7):2894-902. PubMed ID: 19476377
[No Abstract] [Full Text] [Related]
2. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
Champoux JJ
Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
[TBL] [Abstract][Full Text] [Related]
3. A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
Marchand C; Antony S; Kohn KW; Cushman M; Ioanoviciu A; Staker BL; Burgin AB; Stewart L; Pommier Y
Mol Cancer Ther; 2006 Feb; 5(2):287-95. PubMed ID: 16505102
[TBL] [Abstract][Full Text] [Related]
4. Camptothecins as probes of the microenvironments of topoisomerase I--DNA complexes.
Hecht SM
Ann N Y Acad Sci; 2000; 922():76-91. PubMed ID: 11193927
[TBL] [Abstract][Full Text] [Related]
5. Iridoids as DNA topoisomerase I poisons.
Gálvez M; Martín-Cordero C; Ayuso MJ
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin resistance related to drug-induced down-regulation of topoisomerase I and to steps occurring after the formation of protein-linked DNA breaks.
Murren JR; Beidler DR; Cheng YC
Ann N Y Acad Sci; 1996 Dec; 803():74-92. PubMed ID: 8993502
[No Abstract] [Full Text] [Related]
7. Topoisomerase I inhibitors: camptothecins and beyond.
Pommier Y
Nat Rev Cancer; 2006 Oct; 6(10):789-802. PubMed ID: 16990856
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the function of type IB topoisomerases.
Redinbo MR; Champoux JJ; Hol WG
Curr Opin Struct Biol; 1999 Feb; 9(1):29-36. PubMed ID: 10047584
[TBL] [Abstract][Full Text] [Related]
9. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
[TBL] [Abstract][Full Text] [Related]
10. Cellular resistance to camptothecins.
Pommier Y; Gupta M; Valenti M; Nieves-Neira W
Ann N Y Acad Sci; 1996 Dec; 803():60-73. PubMed ID: 8993501
[No Abstract] [Full Text] [Related]
11. Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I.
Guo W; Miao Z; Sheng C; Yao J; Feng H; Zhang W; Zhu L; Liu W; Cheng P; Zhang J; Che X; Wang W; Luo C; Xu Y
Eur J Med Chem; 2010 Jun; 45(6):2223-8. PubMed ID: 20202723
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase I poisons.
Takimoto CH; Kieffer LV; Kieffer ME; Arbuck SG; Wright J
Cancer Chemother Biol Response Modif; 1999; 18():81-124. PubMed ID: 10800479
[No Abstract] [Full Text] [Related]
13. Arylstibonic acids: novel inhibitors and activators of human topoisomerase IB.
Kim H; Cardellina JH; Akee R; Champoux JJ; Stivers JT
Bioorg Chem; 2008 Aug; 36(4):190-7. PubMed ID: 18508107
[TBL] [Abstract][Full Text] [Related]
14. In vivo bioassay to detect irinotecan-stabilized DNA/topoisomerase I complexes in rats.
Barth SW; Briviba K; Watzl B; Jäger N; Marko D; Esselen M
Biotechnol J; 2010 Mar; 5(3):321-7. PubMed ID: 20213647
[TBL] [Abstract][Full Text] [Related]
15. Rapid chromatin reorganization induced by topoisomerase I-mediated DNA damage.
Sun M; Duann P; Lin CT; Zhang H; Liu LF
Ann N Y Acad Sci; 2000; 922():340-2. PubMed ID: 11193917
[No Abstract] [Full Text] [Related]
16. Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin.
Arimondo PB; Bailly C; Boutorine A; Sun JS; Garestier T; Hélène C
C R Acad Sci III; 1999 Sep; 322(9):785-90. PubMed ID: 10547719
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
18. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.
Kerrigan JE; Pilch DS
Biochemistry; 2001 Aug; 40(33):9792-8. PubMed ID: 11502172
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase I inhibitors.
Takimoto CH; Kieffer LV; Arbuck SG
Cancer Chemother Biol Response Modif; 1997; 17():80-113. PubMed ID: 9551210
[No Abstract] [Full Text] [Related]
20. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
